Pathway-Specific Dopamine Abnormalities in Schizophrenia.
about
Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.Towards trans-diagnostic mechanisms in psychiatry: neurobehavioral profile of rats with a loss-of-function point mutation in the dopamine transporter gene.In SilicoModel-driven Assessment of the Effects of Brain-derived Neurotrophic Factor Deficiency on Glutamate and Gamma-Aminobutyric Acid: Implications for Understanding Schizophrenia Pathophysiology.The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review.The dopamine transporter role in psychiatric phenotypes.Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.New Repeat Polymorphism in the AKT1 Gene Predicts Striatal Dopamine D2/D3 Receptor Availability and Stimulant-Induced Dopamine Release in the Healthy Human Brain.Adolescent Stress as a Driving Factor for Schizophrenia Development-A Basic Science Perspective.Presynaptic Dopamine Synthesis Capacity in Schizophrenia and Striatal Blood Flow Change During Antipsychotic Treatment and Medication-Free Conditions.Current Concepts on the Physiopathological Relevance of Dopaminergic ReceptorsErbB4 signaling in dopaminergic axonal projections increases extracellular dopamine levels and regulates spatial/working memory behaviors.Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders.Schizophrenia: What's Arc Got to Do with It?Dysbindin-1 Involvement in the Etiology of Schizophrenia.5-HT2C Agonists Modulate Schizophrenia-Like Behaviors in Mice.Using molecular imaging to understand early schizophrenia-related psychosis neurochemistry: a review of human studies.A mouse model of the schizophrenia-associated 1q21.1 microdeletion syndrome exhibits altered mesolimbic dopamine transmission.A Perceptual Inference Mechanism for Hallucinations Linked to Striatal Dopamine.The impact of early environmental interventions on structural plasticity of the axon initial segment in neocortex.Behavioral Phenotyping of Dopamine Transporter Knockout Rats: Compulsive Traits, Motor Stereotypies, and Anhedonia.Can we use mice to study schizophrenia?Cognitive Function and Monoamine Neurotransmission in Schizophrenia: Evidence From Positron Emission Tomography Studies.Maternal Vitamin D Prevents Abnormal Dopaminergic Development and Function in a Mouse Model of Prenatal Immune Activation.mGluR1-Dependent Long Term Depression in Rodent Midbrain Dopamine Neurons Is Regulated by Neuregulin 1/ErbB SignalingNeuroimmunological Implications of Subclinical Lipopolysaccharide from EnteritidisInterdependency Between Autophagy and Synaptic Vesicle Trafficking: Implications for Dopamine Release
P2860
Q30375583-D03E3E8C-26CB-4D6C-91D6-310CF2ED6C8EQ33588082-E855DEB6-A348-480B-9A87-79BE4BBA803EQ33662831-C044EF5C-DF33-4564-BEB0-2E044954EDBEQ37633236-D9F5B85F-9301-46D3-9A9C-4EBE0829390CQ38648135-0AC5CF71-0ECF-49B9-AE54-83FC666DF8F2Q38699013-60BDF38B-D593-4B92-B25F-E8D9E1B852F7Q38729316-919DFDE2-D1C1-4E08-BD76-98902835C9FDQ38832247-50008517-8CD7-4A12-AB31-A6FA29772DDAQ38848472-9543B21B-4919-4368-85A2-86F27F414141Q39147170-35A0AC02-DC9D-4E95-AA0C-FEA408C81371Q40115060-4D464528-F92A-44BA-83F3-70C01276B02AQ41700939-07ED4924-5B7D-401B-9B6F-70EF415919A2Q42363268-5E927CDE-8840-46C3-AEF1-CA5D462C45D0Q46387449-D85FF5C0-A988-4A02-B22B-243893E7DB7FQ47357220-0C4AAA62-74CB-406D-A28B-32C8C4D3DA76Q47566341-A00A6CCF-5608-4735-B726-5A294E2B73D1Q47569419-6C2773EB-BCC3-4422-BA48-52EC3AA6460AQ48503426-623F9FF2-665F-46A4-9855-CBE4DF04F328Q48596038-B18D3546-9FED-4091-9594-A7B5B26B44C2Q52665626-2662188F-B824-46D8-8B0E-0A8C8DB9D211Q52710394-21791727-B2EF-4830-BFAA-DD0E0FC46DB8Q55305236-5142B2A8-339F-427A-A237-75AE618E56F1Q55430762-1C6E6DD2-B1A9-4684-AFE5-867A3D6B0052Q57486547-2E707E74-BBE0-4A9D-BE38-B0F3C538F516Q58581338-3692F485-99F4-46AC-92B8-135D36992480Q58729447-8CC2FFA1-580B-45F7-96C2-302FA3B5AEE3
P2860
Pathway-Specific Dopamine Abnormalities in Schizophrenia.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մարտին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Pathway-Specific Dopamine Abnormalities in Schizophrenia.
@ast
Pathway-Specific Dopamine Abnormalities in Schizophrenia.
@en
Pathway-Specific Dopamine Abnormalities in Schizophrenia.
@nl
type
label
Pathway-Specific Dopamine Abnormalities in Schizophrenia.
@ast
Pathway-Specific Dopamine Abnormalities in Schizophrenia.
@en
Pathway-Specific Dopamine Abnormalities in Schizophrenia.
@nl
prefLabel
Pathway-Specific Dopamine Abnormalities in Schizophrenia.
@ast
Pathway-Specific Dopamine Abnormalities in Schizophrenia.
@en
Pathway-Specific Dopamine Abnormalities in Schizophrenia.
@nl
P2093
P2860
P1476
Pathway-Specific Dopamine Abnormalities in Schizophrenia.
@en
P2093
Holly Moore
Jodi J Weinstein
Lawrence S Kegeles
Mark Slifstein
Muhammad O Chohan
P2860
P356
10.1016/J.BIOPSYCH.2016.03.2104
P407
P577
2016-03-31T00:00:00Z